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 ABSTRACT 
 
Listeria monocytogenes is a facultative intracellular bacterial pathogen that causes 
disease in humans and animals.  A mutant strain that has lost the ability to control the activity of 
a phospholipase C is attenuated in mice.  This attenuation is not due to a lack of bacterial fitness, 
but appears to result from a modified immune response to infection.  In a competitive assay, the 
mutant strain compromises the ability of wild-type (wt) L. monocytogenes to multiply in the liver 
of infected animals.  To assess how the mutant modifies the hepatic immune response to 
infection, we monitored the kinetics of immune cell recruitment in the liver of infected mice and 
levels of serum inflammatory cytokines up to three days post-infection.  At day 3, an increase in 
neutrophils was only detected in wild-type infected mice, whereas an increase in dendritic cells 
was only detected in mutant infected mice.  Other innate immune cell types were recruited to the 
same levels in mice infected with either wt or mutant bacteria.  Interferon gamma was detected 
in the serum of mice infected with wt bacteria at day 1-3 post-infection, but only at day 2 post-
infection in mice infected with the mutant strain.  Interleukin 12 was only detected in mice 
infected with wt bacteria.  Also, transcriptional profiling of macrophages indicated that immune 
related genes were similarly up-regulated within both mutant and wt infections, while varying 
regulation of pathways revealed possible differences in host response to infection.  At 60 minutes 
post infection mutant bacteria demonstrated increased efficiency at vacuolar escape and 
decreased mitochondrial damage at 90 minutes versus wt.  Together, these results suggested that 
PC-PLC potentiates the host ability to clear L. monocytogenes in a way that does not involve an 
increase in the inflammatory response to infection.
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CHAPTER ONE: 
INTRODUCTION 
 
Listeria monocytogenes is a facultative intracellular, gram-positive bacterium [1,2].  
Human infection commonly occurs through ingestion of contaminated foods, such as raw 
vegetables, hot dogs, deli meats, and dairy products [3,4].  L. monocytogenes will proliferate ex 
vivo at a large range of pH values, low temperatures, and high salinity, making it a common 
pathogen found in ready-to-eat foods [2,5-7].  A portion of the population is at higher risk for 
bacteremia and the associated sequelae, including neonates, older individuals, and pregnant 
women [8,9].  Patients on immunomodulatory treatments or with underlying disease, such as 
certain cancers, human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome 
(AIDS), renal disease, and liver cirrhosis, are also considered to be at a greater risk [10].   
L. monocytogenes uses unique methods for infection and proliferation.  Once ingested by 
the host, L. monocytogenes enters intestinal epithelial cells and translocates through host 
lymphatics and vasculature to the liver and spleen, ultimately proliferating in parenchymal cells 
of the liver and spleen [11].  Initial infection may be asymptomatic or cause febrile enteritis [12].  
Generally, immunocompetent people are able to clear the infection without septicemia and 
associated morbidity; but if bacteria invade the feto-placental and blood brain barriers then 
abortions or meningitis/meningoencephalitis may occur, respectively [2].  A similar 
pathophysiology occurs in ruminants used in agricultural production, often presenting with 
neurologic dysfunction [1,2], and is historically linked to contaminated silage, although this 
connection is debated within the literature [1,13]. 
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The host immune response to L. monocytogenes makes it a model pathogen for 
immunological research.  In order to clear L. monocytogenes infections the host innate and 
adaptive immune responses are triggered [14,15].  The strong cell mediated immunity trigger in 
the host makes it an ideal vaccine vector for targeting both infections and cancerous cells [14].  
Due to the intracellular nature of L. monocytogenes residing in both phagosomal and cytosolic 
regions of the host cell, degraded bacterial proteins are loaded onto both MHC class I and MHC 
class II molecules resulting in activation of both CD4+ and CD8+ T lymphocytes [14].  Thus, 
due to Listeria’s natural ability to up-regulate the immune response and the easy manipulation of 
the bacterial genome, modulation of host’s immunity can be readily developed with L. 
monocytogenes infection, leading to further immunological studies and vaccine development.   
L. monocytogenes is one of the few bacterial species which invades host cells and 
multiplies intracellularly.  The bacterium uses internalin A /E-cadherin interaction, in a species 
specific manner to enter into epithelial host cells and transverse natural host barriers, such as the 
intestinal barrier and feto-placental barrier [16,17]. The bacterium is phagocytized by the host, 
resulting in the formation of a membrane-bound vacuole.  L. monocytogenes will escape from the 
vacuole using a combination of bacterial secreted proteins, including the pore-forming 
hemolysin, known as lysteriolysin O (LLO) and phodphatidylinositol-specific phosholipase C 
(PI-PLC) [18-20].  Upon escape from the vacuole L. monocytogenes replicates within the host 
cytosol and the ActA protein mediates polymerization of host actin filaments into actin comet 
tails [21].  This actin motility is essential for the spread of L. monocytogenes, which uses the 
actin to propel itself from one cell into an adjoining cell forming a double membrane-bound 
vacuole [20].  LLO and the broad range phospholipase C (PC-PLC) are utilized for dissolution 
and escape from the secondary vacuole, followed by further replication and infection [22].  This 
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method of cell-to-cell spread allows L. monocytogenes to colonize adjoining host cells without 
ever leaving the intracellular milieu, resulting in evasion of host humoral immunity [20].   
Upon infection with L. monocytogenes, nonspecific innate immunity is quickly triggered 
to control bacterial proliferation and prevent sepsis during the initial 1-2 days post infection [23].  
Sublethal L. monocytogenes i.v. injection results in rapid uptake by the liver and spleen, 
approximately 90% of bacteria within 10 minutes, and bacteria continue to proliferate 
exponentially for approximately 3-4 days [15,24].  Macrophages and neutrophils are the 
predominant leukocytes at foci of infection within hepatic and splenic tissue during this initial 
period of infection [15].  Resident macrophages, such as Kupffer cells, within the liver play a 
predominant role in the initial trapping of many bacteria, either by phagocytosis or extracellular 
binding [23,25,26]; but a large proportion, 38% reported by Gregory et al., are found associated 
with parenchymal hepatocyes at the 10 minute post infection time point [27].  Neutrophil 
infiltration also plays a critical role in nonspecific early host defense against L. monocytogenes 
[28,29].  Neutrophils are able to engulf and kill extracellular bacteria outside of liver 
parenchymal cells [27] and have demonstrated the ability to lyse infected hepatocytes in order to 
control bacterial numbers within the liver [30].  DCs serve as the crucial link between innate 
immunity and adaptive immunity, by priming the T cell response through antigen presentation 
[31].  CD4 and CD8 T cells are then responsible for the majority of L. monocytogenes induced 
adaptive immunity [14,26]. 
Along with early cellular infiltration, innate immune responses rely on production of 
cytokines, namely tumor necrosis factor α (TNF-α), interferon γ (IFN-γ), and interleukin 12 (IL-
12), and their resultant interaction and effects upon inflammation to mediate infection.  IL-12 
produced by resident macrophages result in natural killer (NK) cells producing IFN-γ, which 
4 
 
then activates macrophages, resulting in increased cytokine synthesis and further NK stimulation 
[32].  Other cell types, such as γ/δ T cells, in peritoneal infection of L. monocytogenes, have also 
been shown to be a key producer of IFN- γ at early time points of infection [33] and IL-12 
production can also be seen in activated neutrophils [34], further demonstrating the complex 
interaction of leukocytes and cytokines involved in innate immunity. 
Activation of PC-PLC is under tight control within the vacuole bound bacteria.  PC-PLC 
is produced as a proenzyme which is inactive until proteolytic cleavage of a 24-amino-acid N-
terminal propeptide [35,36].  The proform of PC-PLC does not efficiently translocate across the 
bacterial cell wall, leading to a pool of PC-PLC at the membrane-cell-wall interface [37,38].  The 
PC-PLC propeptide is a checkpoint in enzymatic activity and promotes accumulation of bacterial 
enzymes at the membrane cell-wall interface [37,39,40].  Both maturation of the proenzyme and 
translocation of pooled protein are under the regulation of the L. monocytogenes metalloprotease 
[41] and dependent upon vacuolar acidification [40,42].  Upon a drop in vacuolar pH the active 
form of PC-PLC is released into the vacuole as a bolus to aid in vacuolar lysis and bacterial 
release into host cytosol [37-39]. 
In our current studies, we look to elucidate the processes by which host cells eliminate 
the L. monocytogenes plcB∆pro mutant more efficiently than wild-type bacteria.  This mutant 
contains a deletion in the propeptide domain of PC-PLC, allowing constitutive secretion of active 
PC- PLC which effectively translocates across the bacterial cell wall at physiologic pH [40].  We 
have previously shown in J774 cells, a murine macrophage cell line, that the mutant behaves 
similarly to wild-type bacteria in regards to invasion, growth, and cell-to-cell spread; but the 
mutant is attenuated in murine models through both oral and i.v. infection [43].  In this study we 
aimed to determine the cause of the plcB∆pro in vivo attenuation.  We find that co-infection of 
5 
 
plcB∆pro mutant and wild-type bacteria in vivo results in attenuation of both strains.  The effect 
of constitutive secretion of PC-PLC on leukocyte migration to the liver was largely similar, with 
notable differences being a lack of significant neutrophil populations and significant increases in 
dendritic cells in mutant infected mice at day 3 post-infection.  Serum cytokine production was 
drastically different in plcB∆pro mutant and wild-type murine infections, showing decreased 
production of IFN-γ and IL-12 at days 1, 2, and 3 post-infection.  Transcriptional analysis 
demonstrated similar responses of immune related genes in macrophage infection with both 
strains in vitro.  Also, the mutant showed increased efficiency at escape from the primary 
vacuole in macrophages and reduced ability to induce mitochondrial fragmentation in the host 
cell, when compared to wild-type L. monocytogenes.  The mutant is able to establish hepatic 
infection; but appears to have an ultimately deleterious effect on proliferation.  Further 
understanding and manipulation of host-pathogen interactions that result from constitutive 
secretion of PC-PLC could allow for immune modulation and possible therapies in the future. 
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CHAPTER TWO: 
MATERIALS AND METHODS 
 
Bacterial strains and growth conditions.  
Listeria monocytogenes 10403S or the murinized derivative inlAm  (NF-L1556/HEL-921) 
[44] were used as wild-type strains.  The plcB∆pro mutant in 10403S (HEL-335) [40] and in 
10403S inlAm (HEL-923) were used as mutant strains.  HEL-923 was generated by allelic 
exchange using plasmid pHEL-913 [44] and HEL-335 [40].  Bacteria were grown overnight in 
BHI at 30°C, passaged 1/10 or 1/100 in BHI and incubated at 30°C, 200 rpm until reaching an 
OD600 of 0.6-0.8.  Bacteria were washed once in PBS, diluted, and suspended in appropriate 
volume for in vitro or in vivo infection. 
 
Animals and housing conditions. 
 Female mice of the BALB/cAnNHsd inbred strain (Harlan, Indianapolis, IN) were used 
for infection experiments and tissue collection.  All mice were murine pathogen free by supplier 
standards.   Mice were held in single-sex groups of 3-5 animals per cage based on the parameters 
of the experiment and maintained at Animal Biosafety Level 2.  Mice were housed in 
individually ventilated, positively pressured cages (Allentown Inc., Allentown, PA) at Cornell 
University, an AAALAC accredited institution.  All experiments were approved by the Cornell 
University Institutional Animal Care and Use Committee.  
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In vivo proliferation.  
Six- to 8-week-old female BALB/c mice were infected by gavage with log-phase 
bacterial cells in 200 µl of PBS.  Mice were sacrificed at specific time points post-infection.  The 
intestines were isolated and flushed with cold PBS to remove all feces.  The intestines were cut 
longitudinally and homogenized in 0.02% NP-40/0.2 mM EDTA.  Serial dilutions were plated on 
LB plates supplemented with streptomycin (200 µg/ml) to determine bacterial counts.  
Alternatively, mice were infected i.v. by retro-orbital injection.  When indicated, the mice were 
perfused post-mortem with PBS to remove hematogenous bacteria before collecting spleen and 
liver.  The organs were homogenized in 2 ml of 0.02% NP40 Alternative (CalBiochem, La Jolla, 
CA) and serial dilutions were plated on LB agar with streptomycin to quantify bacterial load.  In 
order to differentiate bacterial strains, 100-200 colonies were picked from each co-infection 
sample and streaked on egg-yolk  agar containing activated charcoal (0.2%)-treated LB, 25mM 
glucose-1-phosphate, and 1.25% egg yolk.  The constitutive secretion of PC-PLC allows 
differentiation of mutant strain after 24 hours of incubation at 37°C on egg-yolk agar plates [40]. 
 
Detection of leukocytes.   
Six- to 8-week-old female BALB/c mice (Taconic, Hudson, NY) were infected i.v. as 
described elsewhere in the manuscript.  At indicated times post-infection mice were euthanized 
and perfused with PBS in order to remove hematogenous leukocytes.  Liver leukocytes were 
purified.  Briefly, livers were ground through coarse mesh strainers and cells were then washed 
in PBS, and resuspended in Dulbecco’s Modified Eagle Medium (DMEM).  Homogenates were 
digested with 50 mg/ml Type IV collagenase from Clostridium histolyticum (Sigma-Aldrich, St. 
Louis, MO) for 20 min at 37°C, pelleted, and resuspended in PBS.  A single cell suspension was 
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made by straining through 40 μm nylon Cell Strainer (BD Biosciences, Durham, NC).  
Leukocytes were separated from red blood cells and hepatocytes through a discontinuous Percoll 
(GE Healthcare, Piscataway, NJ) gradient.  The leukocytes were then pelleted, resuspended in 
PBS, and counted.  Cells were stained with different combinations of antibodies from 
eBioscience (San Diego, CA): PE anti-CD45 (30-F11), PE-Cy7 anti-CD11b (M1/70), Alexa 
Fluor 647 anti-CD11c (N418), eFluor 660 anti-CD3e (17A2), FITC anti-CD49b (DX5), and 
FITC anti-Ly-6G (1A8). Stained cells were differentiated using a BD FACSCanto II (BD 
Biosciences, Durham, NC) and data were analyzed with FlowJo  (Tree Star Inc, Ashland, OR). 
 
Bone marrow-derived macrophage infections.  
Bone marrow cells were collected from BALB/c mice and macrophages were 
differentiated in medium containing 50% DMEM, 20% Fetal Bovine Serum (FBS), 30% L-cell 
conditioned medium, 100 U/ml Penicillin G,100 μg/ml Streptomycin, 1mM Sodium pyruvate, 
and 2mM L-glutamine.  Differentiated macrophages were seeded at a concentration of 3.6 x 106 
cells in 100 mm petri dishes containing four 12 mm glass cover slips, and incubated overnight at 
37°C, 5% CO2.  Macrophages were infected with either wild-type L. monocytogenes or L. 
monocytogenes plcB∆pro at an MOI of 1.  Cells were washed in PBS at 30 min post infection 
and tissue culture medium was added to dishes.  At one hour post-infection, gentamicin was 
added at a final concentration of 50 μg/ml.  At three hours post-infection, the medium was 
replaced with antibiotic-free medium to prevent intracellular bacterial killing as the mutant 
affects membrane permeability [43].   Samples were collected at 3, 6, and 9 hr p.i. for RNA 
purification.  Cover slips were collected at the same time points to determine bacteria counts as 
previously described. 
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Microarray.  
Total RNA from the BMMΦ infections was isolated and purified using RNeasy Mini Kit 
(Qiagen, Hilden, Germany) per manufacturer’s instructions.  RNA sample purity was assessed 
using Agilent 2100 Bioanalyzer RNA 6000 Nano LabChip (Agilent Technologies, Santa Clara, 
CA).  All samples were >9.1 RIN (RNA Integrity Number).  The samples were processed as 
follows by the Cornell University Life Sciences Core Laboratories Center:  A total of 825 ng per 
sample of Cy3-labelled cRNA was fragmented, blocked, hybridized to Agilent Whole Mouse 
Genome Microarray 4x44K (G4122F), and washed according to manufacturer’s instructions.  
The slides were then scanned using the one-color scan setting for 4x44 array slides (scan area 61 
x 21.6 mm, scan resolution 5um, dye channel set to red and green, and PMT 100%) using the 
Agilent DNA Microarray Scanner (G2505B).  Feature Extraction Software 9.1 (Agilent) 
analyzed the scanned images for background, subtracted and spatially detrended processed signal 
intensities, and excluded non-uniform outliers flagged in feature extraction (protocol GE1-
105_DEC8 and Grid: 012391_D_20060331).  Data was analyzed using GeneSpring11.5 (Agilent 
Technologies, Santa Clara, CA), threshold to raw signal was set to 1.0, shifted to 75.0 percentile 
to remove lower percentile intensity values (background noise from probes where gene is not 
expressed), and baseline set to median of all samples.  Experimental groupings were created by 
dividing the samples into conditions (a) wild-type infected (triplicate),(b) plcB∆pro mutant 
(triplicate), and (c) uninfected (duplicate).  Interpretations were created using the average 
replicates in condition, non-numeric, continuous parameters, and including detected, not 
detected, and compromised flags.  Statistical analysis was then performed between conditions 
(a)/(c) & (b)/(c), unpaired T-test, no correction, p-value <0.05.  We then performed functional 
annotation using our significant gene lists through the Database for Annotation, Visualization 
10 
 
and Integrated Discovery (DAVID 6.7, National Institute of Allergy and Infectious Diseases – 
National Institutes of Health) to find pathways significantly affected by up- or down-regulated 
genes [45]. 
 
Cytokine assays.   
Whole blood was collected from mice by cardiac puncture immediately following 
euthanasia with CO2.  Cytokine serum levels were determined using ELISA Ready-SET-Go! 
Kits from eBioscience (San Diego, CA) for Mouse IL-1ß, TNF-α, IL-12 p70, and IFNγ.  Corning 
96 Well High Bind Microplates were used (Corning Inc., Corning, NY) for the assays and the 
results were read using a BioTek ELx808 Absorbance Microplate Reader (BioTek, Winooski, 
VT). 
 
Vacuolar escape assays.   
Bone marrow derived macrophages from BALB/c mice were used for this assay.  
Differentiated macrophages were seeded on cover slips in 35 mm tissue culture dishes at a 
concentration of approximately 6 x 105 cells/dish and infected the following day with wild-type 
L. monocytogenes or L. monocytogenes plcB∆pro at a MOI of 5 [46].  After 30 min incubation at 
37°C, 5% CO2, the cells were washed three times with PBS and either  fixed in formalin or 
incubated for 30 or 60 more minutes in tissue culture medium supplemented with gentamicin (10 
µg/ml), before being washed and fixed.  Bacteria and actin were stained for fluorescence 
microscopy as previously described [47].  Samples were examined using a Zeiss Axio Imager 
M1 and AxioCam MRm (Carl Zeiss Microscopy, Thornwood, NY).  Intracellular bacteria were 
scored as being decorated with actin (cytosolic) or not (vacuolar). 
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Mitochondrial fragmentation assays.  
HELA cells were trypsinized and seeded onto coverslips in 35 mm tissue culture dishes at 
a concentration of 1x 106 cells per dish in RPMI 1640, 10% FBS.  After an overnight incubation, 
cells were infected with wild-type L. monocytogenes or L. monocytogenes plcB∆pro at a MOI of 
50 and incubated for 90 min at 37°C, 5% CO2.  Pre-warmed MitoTracker Deep Red FM 
(Invitrogen, Eugene, OR) was then added to media at a concentration of 300 nM for 15 minutes 
followed by 3 washes in pre-warmed medium.  Cells were fixed in pre-warmed formalin for 15 
minutes at 37°C, 5% CO2, then with acetone on ice for 5 minutes.  Bacteria were stained for 
immunofluorescence as per manufacturer’s instructions (Invitrogen).  Coverslips were mounted 
on glass slides using ProLong Gold Antifade Reagent with DAPI (Invitrogen, Eugene, OR).  
Samples were examined using Zeiss Axio Imager M1 and AxioCam MRm (Carl Zeiss 
Microscopy, Thornwood, NY). 
 
Ubiquitination assays.   
BMMΦ from BALB/c mice were used for this assay.  Differentiated macrophages were 
seeded on 18 x 18 mm glass cover slips in 6-well tissue culture plates at a concentration of 
approximately 1 x 106 cells/well in BMMΦ media and infected the following day with wild-type 
L. monocytogenes or L. monocytogenes plcB∆pro at a MOI of 0.5.  After 30 min incubation at 
37°C, 5% CO2, the cells were washed three times with PBS.  After 60 min incubation 1 μg/ml 
gentamicin was added and cells were incubated for a total of 4 hrs.  Samples were fixed in 
formalin and blocked/permeablized. Coverslips were stained with biotin-conjugated FK2 (Enzo 
Life Sciences, Farmingdale, NY) and then mounted on glass slides using ProLong Gold Antifade 
Reagent with DAPI (Invitrogen, Eugene, OR). Samples were examined using a Zeiss Axio 
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Imager M1 and AxioCam MRm (Carl Zeiss Microscopy, Thornwood, NY).  Intracellular 
bacteria were scored as being ubiquitin decorated or not. 
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CHAPTER THREE: 
RESULTS 
 
Attenuation of the plcB∆pro mutant is unlikely due to a lack of bacterial fitness.  
Previously, we showed using a competitive infection assay that L. monocytogenes 
plcB∆pro is outcompeted by wild-type strain in the intestines, liver, and spleen of BALB/c mice 
at days 2, 3, and 4 following infection by gavage [43].  To assess whether this attenuation was 
due to a defect in initial colonization of the intestines, we infected mice by gavage with wild-
type strain or the plcB∆pro mutant and monitored intestinal colonization at early time points 
post-infection.  The results indicated that L. monocytogenes plcB∆pro is as efficient as wild-type 
strain at colonizing the intestines of BALB/c mice within the first 28 hours post-infection (Fig. 
1a).  However, a statistically significant difference in bacterial numbers was observed by 40 
hours post-infection, with the mutant strain being less abundant than wild-type.   
Previously, we also showed that, following an i.v. infection, the mutant competed equally 
with wild-type strain in the initial stages of infection [43].  Using the competitive indexes and 
total bacterial numbers reported in the Yeung paper for the i.v. infection assay [43], we plotted 
the kinetics of bacterial growth in the liver and spleen.  The results indicated that mutant and 
wild-type strains were found in equivalent numbers by 7 hours post-infection, and increased by 
1-2 logs in numbers between 7 and 24 hours post-infection (Fig. 1b).  However, mutant 
attenuation became apparent with time as mutant bacterial numbers were 34 and 66 fold lower 
than wild-type by 72 hours post-infection in spleen and liver respectively.  This attenuation in 
virulence was further emphasized by determining that the mutant LD50 was increased a hundred 
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fold in BALB/c mice: 2 x 106 for the mutant vs. 2 x 104 for wild-type (data not shown).  Overall, 
these results suggested that virulence attenuation of L. monocytogenes plcB∆pro is unlikely due 
to an initial lack of bacterial fitness, since the mutant is as efficient as wild-type strain at 
colonizing the intestines, spleen, and liver in the initial stage of infection and that it is also 
capable of multiplying in tissues.  
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Figure 1. Kinetics of L. monocytogenes growth in tissues of infected BALB/c mice.  A. Total 
CFU recovered from intestinal tissues of mice infected by gavage with 6 x 109 L. monocytogenes 
inlAm (round symbols) or inlAm plcB∆pro (squares symbols).  Each data point represents counts 
from one mouse and horizontal bars represent the mean.  The difference in CFU between the two 
bacterial strains is statistically significant only at 40 hours post-gavage: Student’s t test unpaired 
two-tailed p value <0.01 (**).  Total CFU recovered from the liver (B.) and spleen (C.) of mice 
co-infected i.v. with 104 wild-type L. monocytogenes (round symbols) and 104 of the plcB∆pro 
mutant (square symbols).  Bacterial numbers were calculated from data reported in Yeung et al 
[43].  Each time point represents the mean ± SEM of four to seven mice.  Data were analyzed by 
the Student’s t test and paired two-tailed p values are: * <0.05, ** < 0.01, *** <0.001.  
Experiment in A performed by Hélène Marquis. 
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The plcB∆pro mutant interferes with the growth of wild-type strain.   
The above results indicated that the loss of regulation of PC-PLC activity compromises 
the ability of L. monocytogenes to expand the infection, and we speculated that attenuation of the 
plcB∆pro mutant results from a change in how the host perceives signals received from the 
infected cells.  To test this possibility, we assessed whether the mutant strain would affect the 
growth of wild-type bacteria during a mixed infection.  Three groups of mice were infected i.v.: 
the 1st group received ~104 L. monocytogenes inlAm, the 2nd group received twice as many of 
the mutant strain (inlAm plcB∆pro), and the third group received the same inoculum as groups 1 
and 2 together.  Bacterial counts in spleen and liver were determined at 72 hours post-infection 
and the wild-type and mutant strains were differentiated by plating isolated colonies on egg yolk 
agar to detect phospholipase activity.  No significant changes in numbers of wild-type and 
plcB∆pro bacteria were seen in the spleen of mice when comparing single strain infections to 
mixed infections (Fig. 2a).  Also, no significant changes in numbers of plcB∆pro bacteria were 
seen in the liver of mice when comparing single strain infections to mixed infections (Fig. 2b).  
However, there was a reproducible statistically significant difference in the numbers of wild-type 
bacteria recovered from the liver of mice when comparing single strain infections to mixed 
infections.  Overall, these results show that wild-type L. monocytogenes does not affect the 
growth of the plcB∆pro mutant, but the plcB∆pro mutant has a negative effect on the growth or 
survivability of the wild-type strain in the liver of co-infected mice.  
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Figure 2.  The L. monocytogenes plcB∆pro mutant interferes with growth of wild-type 
bacteria in the liver of infected BALB/c mice.  BALB/c mice were infected i.v. with 7.0-8.5 x 
103 CFU of L. monocytogenes inlAm (wt) or 1.7 x 104 CFU of inlAm plcB∆pro (∆pro), or with 
both strain at the same concentrations (mix).  Bacterial counts in spleen (A) and in liver (B) were 
determined at 72h post-infection.  Each data point represents counts from one mouse and 
horizontal bars represent the mean.  For the mix infection, specific numbers of wt (mix wt) and 
mutant (mix ∆pro) recovered were determined.  The difference in CFU between the single and 
mix infections was statistically significant for wild-type strain recovered from the liver: 
Student’s t test unpaired one-tailed p value <0.05 (*).  Experiment performed in collaboration 
with Lauren Griggs. 
 
The plcB∆pro mutant does not enhance the innate immune response to infection in vivo.   
Due to the significant effect of L. monocytogenes plcB∆pro on the virulence of wild-type 
L. monocytogenes, we hypothesized that the mutant enhances or hastens the host innate immune 
response to infection.  To test this hypothesis, the kinetics of leukocyte recruitment to the liver of 
infected mice was examined.  BALB/c mice were infected intravenously with 104 of either the 
wild-type strain or the L. monocytogenes plcB∆pro mutant.  At 1, 2, and 3 days post infection 
mice were sacrificed and liver leukocytes were purified and analyzed by FACS.  Total numbers 
of T lymphocytes, macrophages, neutrophils, natural killer (NK) cells, NK-T cells, and dendritic 
cells were determined.  No changes were observed between control and infected mice at day 1 
and 2 post-infection, except for a 4-fold increase in macrophages (p = 0.008) at day 2 post-
B. A. 
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infection in mutant-infected mice.  At day 3 post-infection, a variety of innate immune cells were 
significantly increased in the liver of mice infected with either the wild-type or mutant strains 
(Fig. 3).  Interestingly, an increase in neutrophils was only detected in wild-type infected mice, 
whereas an increase in dendritic cells was only detected in mutant infected mice.   
 
 
 
 
 
 Figure 3. Total number of immune cells types recruited to the liver of infected BALB/c 
mice.  Mice were injected with 104 L. monocytogenes inlAm (wild-type), 104 inlAm plcB∆pro 
(plcB∆pro), or sterile PBS (uninfected).  Mice were sacrificed at 72 hours post-infection, livers 
were perfused with PBS, and leukocytes were purified.  Purified leukocytes were stained with 
specific antibodies and analyzed by FACS to differentiate the various types of cells.  T cells 
(CD45+, CD3+, CD49b-), NK cells (CD45+, CD3-, CD49b+), NK-T cells (CD45+, CD3+, 
CD49b+), neutrophils (CD45+, CD11b+, CD11c-, Ly6G+), macrophages (CD45+, CD11b+, 
CD11c-, Ly6G-), and dendritic cells (CD45+, CD11b+/-, CD11c+, Ly6G-).  Data were analyzed by 
the Student’s t test comparing uninfected to infected groups of mice within each experiment.  P 
values are: * <0.05, ** < 0.01. n=3 per group within each experiment. Experiment performed in 
collaboration with Alan Pavinski Bitar. 
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To further elucidate the innate immune response to infection, serum levels of pro-
inflammatory cytokines were measured.  No differences between wild-type and mutant infected 
mice were detected in serum levels of interleukin-1β (IL-1ß), interleukin 10 (IL-10), and tumor 
necrosis factor alpha (TNF-α) (data not shown).  However, IL-12 and interferon gamma (IFN-γ) 
were significantly elevated in wild-type infected mice at day 2 and 3 post-infection, respectively, 
but not in mutant infected mice (Fig. 4).  Together, the data suggest that L. monocytogenes 
plcB∆pro does not enhance the innate immune response to infection. 
 
 
 
 
Figure 4. The plcB∆pro mutant does not generate a pro-inflammatory response in infected 
mice.  BALB/c mice were injected with 104 L. monocytogenes inlAm (wt), 104 inlAm plcB∆pro 
(∆pro), or sterile PBS (control).  Mice were sacrificed at 24 (d1), 48 (d2) or 72 (d3) hours post-
infection and blood was immediately collected.  Serum levels of IL-12 (A) and IFN-γ (B) were 
determined by ELISA.  Data were analyzed by ANOVA using a Tukey’s multiple comparison 
test.  *: p value of <0.05. n=3 per group. ELISA performed by Alan Pavinski Bitar. 
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Transcriptional profiling does not reveal differences in the expression of immune related 
genes in wild-type and mutant infected macrophages.   
To further assess host cell response to infection, we examined the transcriptional 
response of mouse bone marrow derived macrophages infected with wild-type L. monocytogenes 
or the plcB∆pro mutant.  As previously reported in murine macrophages, genes coding for IFNβ, 
IL-6, TNF-α, IL-1α, and IL-1β were among the most abundant transcripts in infected cells, 
validating our microarray data [48,49].  Moreover, our results indicate that there is a similar 
pattern of expression with most immune response genes at 3, 6, and 9 hours post-infection in 
cells infected with wild-type strain or the plcB∆pro mutant (Table 1).  Heat maps illustrate the 
similarities between genes expressed by wild-type strain or the plcB∆pro mutant, while both are 
increased over the uninfected controls, and further demonstrate the changes in overall immune 
related expression between the 3, 6, and 9 hour post-infection time points (Fig. 5).  These data 
suggest that the L. monocytogenes plcB∆pro mutant does not modulate the macrophage innate 
immune response differently than wild-type bacteria.  
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Table 1.  Immune-related gene expression. 
Expression levels of 43 immune-related genes of macrophages after infection with either 
L. monocytogenes inlAm or inlAm plcB∆pro at 3, 6, and 9 hours.  Results are shown as 
mean of fold change compared to uninfected controls in three replicates for each 
infection at the given time point.  Significant genes (bolded) have a P-value < 0.05 
based on Student's t test analysis. 
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Table 1.  Immune-related gene expression. 
 3 hrs 6 hrs 9 hrs  
GeneSymbol plcB∆pro wt plcB∆pro wt plcB∆pro wt Description 
Cytokines 
Ifna2 3.14 2.48 7.48 7.21 6.76 6.47 Interferon alpha 2  
Ifnab -1.05 -1.21 -1.10 1.32 1.14 1.13 Interferon alpha B 
Ifnab1 44.19 44.83 352.79 232.92 79.92 70.90 Interferon beta 1 
Il1a 1.93 1.77 5.95 5.74 28.61 24.58 Interleukin 1 alpha 
Il1b 2.67 2.23 16.78 30.05 55.08 51.86 Interleukin 1 beta 
Il6 3.68 3.28 489.26 513.41 62.68 67.24 Interleukin 6 
Il7 1.59 1.63 2.14 3.08 1.59 1.72 Interleukin 7 
Il10 1.10 1.06 4.77 2.34 5.12 5.14 Interleukin 10 
Il12b 2.60 2.14 7.27 8.92 21.90 19.70 Interleukin 12b (p40) 
Il15 -1.17 -1.29 3.08 4.46 2.58 2.69 Interleukin 15 
Il18 1.00 -1.00 2.13 2.13 3.73 4.06 Interleukin 18 
Tnf 5.71 6.13 57.39 41.07 37.25 31.70 Tumor necrosis factor 
Cytokine receptors 
Tnfrsf1b 1.00 -1.01 -1.22 1.15 1.26 1.22 Tumor necrosis factor receptor 
superfamily, member 1b 
Chemokines 
Ccl2 1.78 1.75 33.77 33.29 30.33 32.81 Chemokine (C-C motif) ligand 2 
Ccl3 4.29 3.87 13.84 19.92 24.59 25.38 Chemokine (C-C motif) ligand 3 
Ccl5 1.61 1.64 61.72 81.38 25.38 31.25 Chemokine (C-C motif) ligand 5 
Ccl7 2.49 2.54 80.05 73.61 60.70 65.27 Chemokine (C-C motif) ligand 7 
Ccl8 1.03 -1.03 1.32 1.85 1.50 1.46 Chemokine (C-C motif) ligand 8 
Ccl12 1.26 1.26 95.12 83.39 60.19 69.67 Chemokine (C-C motif) ligand 12 
Cxcl1 10.17 10.56 26.30 36.03 77.43 69.54 Chemokine(C-X-C motif) ligand 1  
Cxcl2 7.91 7.31 32.78 42.08 77.71 79.52 Chemokine(C-X-C motif) ligand 2 
Cxcl3 3.53 3.04 6.31 9.61 14.69 17.32 Chemokine(C-X-C motif) ligand 3 
Cxcl9 1.07 -1.30 19.36 28.69 19.37 20.88 Chemokine(C-X-C motif) ligand 9 
Cxcl10 3.93 3.88 134.57 132.24 124.36 128.29 Chemokine(C-X-C motif) ligand 10 
Cxcl11 1.22 1.10 111.70 112.36 148.52 163.77 Chemokine(C-X-C motif) ligand 11 
Cxcl16 1.32 1.27 1.69 1.66 2.20 2.03 Chemokine(C-X-C motif) ligand 16 
Cx3cl1 1.32 1.26 1.87 2.10 3.13 2.32 Chemokine(C-X3-C motif) ligand 1 
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Table 1 (continued).  Immune-related gene expression. 
 3 hrs 6 hrs 9 hrs  
GeneSymbol plcB∆pro wt plcB∆pro wt plcB∆pro wt Description 
Chemokine receptors 
Ccr2 -1.23 -1.22 -3.51 -1.69 -2.47 -2.24 Chemokine (C-C motif) receptor 2  
Ccr7 1.48 1.17 1.59 2.29 4.25 3.82 Chemokine (C-C motif) receptor 7  
Transcription factors 
Irf7 -1.13 -1.02 11.55 8.63 4.76 4.54 Interferon regulatory factor 7 
Nfkb1 1.36 1.28 1.91 1.95 2.35 2.34 NF-kappa-B DNA binding subunit 
Innate immune receptors 
Myd88 1.19 1.20 2.79 2.17 2.56 2.57 Myeloid differentiation primary 
response gene 88 
Tlr2 1.67 1.62 2.21 3.55 6.15 6.12 Toll-like receptor 2 
Tlr3 -1.10 -1.17 6.04 8.48 4.68 5.09 Toll-like receptor 3 
Nod1 1.00   -1.02 6.05 5.75 3.88 4.26 Nucleotide-binding oligomerization 
domain containing 1 
Nod2 2.13 2.04 14.70 7.73 5.88 6.51 Nucleotide-binding oligomerization 
domain containing 2 
Other immune related molecules 
Icam1 1.71 1.86 2.08 2.45 3.97 3.64 Intercellular adhesion molecule 1 
Ifit1 1.91 1.50 94.81 126.99 49.83 53.48 Interferon-induced protein with 
tetratricopeptide repeats 1 
Ifit2 1.06 1.02 65.33 122.11 53.07 61.86 Interferon-induced protein with 
tetratricopeptide repeats 2 
Ifit3 1.00 -1.06 84.87 110.22 57.30 61.78 Interferon-induced protein with 
tetratricopeptide repeats 3 
Casp1 1.07 -1.04 1.83 2.06 1.75 2.04 Caspase 1 
C3 1.10 1.01 2.60 2.07 2.42 2.52 Complement component 3 
Peli1 1.15 1.16 4.14 4.44 1.92 1.79 Pellino 1 
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Figure 5. Host transcriptional response of immune related genes during L. monocytogenes 
infection.  Expression levels of 43 immune-related genes of macrophages after infection with 
either L. monocytogenes inlAm or inlAm plcB∆pro at 3, 6, and 9 hours.  The color scale represents 
a 3-color fold change range of 0 (blue), 50 (yellow), and 100 (red) with fold changes between 0-
100 resulting in a blend of the relative colors and fold changes below 0 being blue and above 100 
being red.  Empty slots represent non-significant (ns) genes for infection and time-point.  Results 
are shown as mean of fold change compared to uninfected controls in three replicates for each 
infection.    
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The plcB∆pro mutant is more efficient than wild-type at vacuolar escape.  
 Further examination of the microarray data revealed that the caspase-1 gene, involved in 
the  inflammasome pathway [50], was significantly up regulated by 2.06 fold in wild-type, but 
not mutant infected mouse BMMΦ cells at the 6 hour time point.  The ability of L. 
monocytogenes to activate the inflammasome is dependent on listeriolysin O (LLO), which 
enables bacterial escape from vacuoles [51].  Additionally, the mannose-6-phosphate receptor 
was down regulated by 1.10 fold in mutant infected cells and up regulated in wild-type infected 
cells by 1.08 fold at the 3 hour time point.  Although small, these differences were statistically 
significant.  This was an interesting finding as LLO pore forming activity is dependent on the 
host thiol-reductase GILT (gamma interferon inducible thiol-reductase) that requires the 
mannose-6-phosphate receptor to reach the L. monocytogenes containing vacuole [52].  Given 
that LLO is essential for escape from vacuoles in L. monocytogenes [53], and we noted 
significant differences in genes associated with this pathway, we compared the efficacy of wild-
type and mutant bacteria to escape vacuoles  in murine bone marrow-derived macrophages.  To 
quantify bacterial escape at given time points we co-stained infected cells for bacteria and actin, 
as actin decorates exclusively cytosolic bacteria [47,54].  The data indicates that L. 
monocytogenes plcB∆pro is more efficient than wild-type bacteria at escaping vacuoles early 
during infection, as a statistically significant difference was detected at 60 min post-infection, 
but absent by 90 min post-infection (Fig. 6).  These results indicate that the observed changes in 
transcriptional activity of genes involved in inflammasome and vacuolar transport are unlikely 
due to changes in the functionality of LLO.  The increased efficiency of escape could be caused 
by active PC-PLC initiating vacuolar lysis at an earlier time point in the mutant strain.
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Figure 6. Ratio of L. monocytogenes plcB∆pro vacuolar escape versus wild-type L. 
monocytogenes.  Macrophages were infected with either L. monocytogenes inlAm or inlAm 
plcB∆pro for 60 or 90 min.  (A) The cells were then fixed and stained as previously described 
[47], with DAPI for nuclei, α-Listeria for bacteria, phalloidin for actin and then merged.  (B) 
Bars represent mean ± SEM of the ratio of total inlAm plcB∆pro /L. monocytogenes inlAm 
escaped bacteria counted from 10-20 fields per experiment.  Original data from independent 
experiments was arcsine transformed and analyzed by the paired Student’s t test comparing L. 
monocytogenes inlAm or inlAm plcB∆pro vacuolar escape within each timepoint.  *: p value of 
<0.05. n=5 for 60 min and n=3 for 90 min.  Experiments performed by Delbert Abi Abdallah.  
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Mitochondrial dynamics is less affected by the plcB∆pro mutant than by wild type bacteria. 
The microarray data also revealed a differential expression pattern for mitochondria 
genes related to respiratory complexes II to V, showing significant up-regulation of multiple 
genes within these complexes in wild-type but not in mutant-infected cells.  It has previously 
been demonstrated that L. monocytogenes induces transient mitochondrial fragmentation as a 
strategy to promote its intracellular growth [55,56].  Therefore, we speculated that the plcB∆pro 
mutant was not as efficient as wild-type L. monocytogenes in interfering with cellular physiology 
to promote its intracellular growth.  For this purpose, HeLa cells were infected with wild-type or 
the mutant strain of L. monocytogenes, stained with fluorescent Mito Tracker, fixed and 
examined at 90 minutes post-infection.  Based on three independent experiments the mean 
number of cells with fragmented mitochondria was significantly lower in mutant versus wild-
type infected cells (Fig. 7), indicating that the mutant is less efficient than wild-type L. 
monocytogenes in causing mitochondria fragmentation, possibly contributing to its attenuation.   
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Figure 7. Percentage of HeLa cells with fragmented mitochondria after infection with L. 
monocytogenes plcB∆pro or wild-type L. monocytogenes.  HeLa cells were infected with either 
L. monocytogenes inlAm or inlAm plcB∆pro for 90 min.  (A) The cells were fixed and stained with 
DAPI for nuclei, α-Listeria for inlAm plcB∆pro, and Mito Tracker for mitochondria.  The 
negative row demonstrates normal mitochondria and the positive row demonstrates 
mitochondrial fragmentation.  (B) Bar graph representing the mean ± SEM of percentage of 
HeLa cells with mitochondrial fragmentation after infection with L. monocytogenes inlAm, inlAm 
plcB∆pro or uninfected control.  Data were analyzed by the paired Student’s t test comparing 
cells infected with either L. monocytogenes inlAm or inlAm plcB∆pro.  *: p value of <0.05 for 
three independent experiments.  Experiments performed by Delbert Abi Abdallah. 
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The plcB∆pro mutant does not enhance ubiquitination of bacteria within the host cytosol. 
Conjugation of ubiquitin on bacterial surfaces followed by proteasomal degradation is a 
defense mechanism used by mammalian cells to target both gram-negative and gram-positive 
bacteria within the host cytosol [57].  L. monocytogenes avoids ubiquitination through actin 
based motility and this phenomenon is dependent on de novo bacterial protein synthesis [57].  
Our microarray data revealed that the ubiquitin mediated proteolysis pathway was significantly 
up regulated at the 3 hour time point in the mutant infection, but not the wild-type infection.  
Based on the transcriptional data and reduced cytosolic virulence factors displayed by the mutant 
we hypothesized that the mutant could be undergoing increased ubiquitination and ultimately 
proteasome degradation.  We used the FK2 antibody, which interacts with mono- and poly-
ubiquitinated proteins but not free ubiquitin [58], to determine if  increased ubiquitination was 
occurring during mutant bacterial infection of macrophages (Fig. 8).   Ubiquitin positive bacteria 
at 4 hrs post infection were not significantly different in mutant or wild-type infected cells.  
These results reveal that the mutant does not enhance ubiquitination of bacteria within 
macrophage cytosol, but it does not exclude the possibility that ubiquitination of specific host 
proteins is enhanced in mutant-infected cells. 
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Figure 8. Ubiquitination of L. monocytogenes within macrophage host cells.  Macrophages 
were infected with either L. monocytogenes inlAm or inlAm plcB∆pro for 4 hours. The cells were 
fixed and stained with DAPI for nuclei, α-Listeria for bacteria, and α-ubiquitin for ubiquitinated 
proteins.  The white arrows indicate ubiquitinated proteins surrounding intracellular L. 
monocytogenes.    
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CHAPTER FOUR: 
DISCUSSION 
 
The results of this study show that a L. monocytogenes mutant that has lost the ability to 
regulate the activity of PC-PLC is attenuated in vivo and has a deleterious effect on wild-type 
bacteria during co-infection.  Interestingly, this deleterious effect was observed specifically in 
the liver of infected mice.  We hypothesized that the plcB∆pro mutant enhances the innate 
immune response to infection.  However, the data did not support this hypothesis.  Nevertheless, 
differences were observed in the intracellular life cycle of the mutant and the impact of infection 
on mitochondrial integrity. 
We observed that constitutive secretion of active PC-PLC by L. monocytogenes plcB∆pro 
enhances the efficiency of bacterial escape from primary vacuoles in macrophages.  In 
retrospect, it is not surprising that L. monocytogenes plcB∆pro is more efficient at escaping 
vacuoles than wild-type strain, considering that PC-PLC would start hydrolyzing vacuolar 
membrane phospholipids as the vacuole is being formed as opposed to when the vacuole 
becomes acidified at a later time point [59].  However, this effect seems to be cell type 
dependent as the efficiency of escape from vacuoles was not enhanced in human epithelial cells 
[54].  It is conceivable that a more rapid transit from the vacuole to the cytosol in macrophages 
influences the innate immunity-related signaling pathways that are induced by L. 
monocytogenes.  Accordingly, 32-33% more genes related to the Toll-like receptor signaling 
pathway and MAPK signaling pathway were activated in wild-type-infected cells compared to 
mutant infected cells at 3 hours post-infection.  Yet, the cytosolic signaling pathways such as the 
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NOD-like signaling pathway, the cytosolic DNA signaling pathway, and the RIG-1 like receptor 
signaling pathway were activated to similar levels in wild-type and mutant infected cells.  
Although down-regulation of the immune response to infection can be beneficial in some 
instances, it remains to be determined whether or not attenuation of the L. monocytogenes 
plcB∆pro mutant is due to a decrease in the activation of immune signaling pathways associated 
with vacuolar bacteria.  
L. monocytogenes has been shown to cause mitochondrial fragmentation, affecting host 
cell homeostasis in favor of intracellular growth of bacteria [55,56].  Accordingly, our 
microarray data indicated that expression of genes related to mitochondrial respiratory 
complexes II to V were up-regulated during infection with wild-type bacteria suggesting 
mitochondrial dysfunction.  In mutant infected cells, only genes related to mitochondrial 
respiratory complex I were up-regulated indicating a much lower degree of mitochondrial 
dysfunction. Moreover, mitochondrial fragmentation was significantly less prevalent in cells 
infected with the mutant strain than with wild-type strain.  Mitochondrial fragmentation is 
dependent on LLO, but there is no evidence that LLO made by L. monocytogenes plcB∆pro lacks 
functionality as mutant bacteria show an increased rate of escape from vacuoles, which is in 
large part mediated by LLO.  Perhaps active PC-PLC interacts with LLO in the cytosol of 
infected cells, preventing it from causing mitochondrial damage. Alternatively, PC-PLC might 
modify the mitochondrial membrane in a way that reduces the effect of LLO.  These early host-
pathogen interactions should be more closely examined to elucidate the effect that PC-PLC may 
play in altered cellular response to infection. 
Neutrophils can play a significant role in the killing of extracellular bacteria [27,29]; but 
their contribution to controlling intracellular Listeria monocytogenes infections within the liver is 
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debated.  Neutrophils  are known to lyse L. monocytogenes infected hepatocytes within foci of 
infection [30].  Also, studies have demonstrated that after i.v. infection in mice neutrophil 
populations within the liver increase in direct relation to a reduction in L. monocytogenes 
recovered from the liver during the first 6 hours post-infection; yet these studies use nearly 3 logs 
the bacterial dose used in our experiments [27]. It has been demonstrated that depletion of 
neutrophils has drastic effects on survivability of immunocompetent mice early in infection, with 
this effect completely abrogated by day 4 post-infection [29]; however, this study was performed 
using anti-Gr-1 antibodies (clone RB6-8C5) which has been shown to deplete neutrophils and 
monocytes [60].  Thus, mice treated with RB6-8C5 demonstrate immune responses based on 
altered leukocyte population beyond solely neutrophil depletion.  A recent study demonstrates 
that specific depletion of neutrophils, with the Ly6G-specific antibody 1A8, does not 
significantly alter survivability of mice i.v. infected with L. monocytogenes [61].  Furthermore, 
when neutrophil-depleted mice are infected with either low or high doses of Listeria 
monocytogenes, ~104 CFU or ~3.5 x 104 CFU respectively, only the high doses have been shown 
to significantly increase mortality [62].  This suggests low doses of L. monocytogenes in mice, 
such as in our study, would be more significantly affected by leukocytes other than neutrophils. 
Accordingly, mice infected with the attenuated mutant strain had a significant increase in the 
number of liver macrophages at day 2 post-infection, which might have contributed more 
significantly than neutrophils to clearance of the bacteria. 
The lack of significant neutrophil populations in mutant infected mice, unlike wild-type 
infected mice, at day 3 post-infection is an interesting finding.  It is possible that the 
constitutively secreted PC-PLC caused an earlier influx of neutrophils within the liver, leading to 
an earlier decline in the overall population that became apparent by day 3 post-infection or that 
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these neutrophils present demonstrated increased efficiency at killing mutant bacteria over wild-
type, allowing fewer cells to overcome the hepatic infection.  However, we did not detect any 
difference at days 1 and 2 post-infection.  Another possibility for the decrease in neutrophil 
population is that the mutant strain is cytotoxic to neutrophils.  PC-PLC is able to hydrolyze all 
phospholipids within mammalian cells [59,63].  Massive release of activated PC-PLC from 
multiple vacuoles into the host cytoplasm has been shown to be cytotoxic to J774 cells in vitro 
[37].  While this mutant, with constant secretion of active PC-PLC, is not cytotoxic in vitro, 
compromised host cell membrane integrity is seen in a cell-to-cell spread dependent manner 
[43].  The effect of increased amounts of active PC-PLC within neutrophils in vivo is unknown.  
Future studies of neutrophil recruitment should focus on earlier time points post infection and 
viability of cells.    
The lack of interferon γ (IFN-γ) and interleukin 12 (IL-12) production, two of the 
primary inflammatory cytokines in L. monocytogenes infection, in mutant infected mice is 
interesting.  Despite the abundance of natural killer (NK) cells, one producer of IFN-y, recruited 
to the liver during infection with the mutant we see a significant decrease in production of this 
cytokine at day 3 post-inoculation.  IFN-γ is needed to induce resistance to L. monocytogenes in 
immunocompetent mice through increased microbicidal activity against L. monocytogenes 
through production of reactive nitrogen and oxygen intermediates [64,65], so our lack of IFN-γ 
would be predicted to aid in persistence of mutant infection.  Despite a significant increase of 
dendritic cells at day 3 post-inoculation of mice with the mutant, a lack of IL-12 would suggest 
that macrophages are not being activated [64].  This discrepancy suggests that there is another 
mechanism, independent of macrophage and T cell activation, responsible for attenuation of this 
mutant strain.  
35 
 
Our transcriptional response data also does not explain the attenuation of the mutant from 
an immune gene regulation perspective.  It showed many similarities among genes up-regulated 
by mutant and wild-type infection, with few specific differences.  An important finding that we 
can conclude from our microarray data is that mutant infection of macrophages does trigger a 
primary cytosolic response.  Seven host genes have been identified to be up regulated as part of 
the primary cytosolic response during L. monocytogenes infection in macrophages, independent 
of secondary signaling and vacuolar response [48].  Five of the seven genes indicated in primary 
cytosolic response, IFNβ, PEL1, IFIT1, IFIT2, and IFIT3, are up regulated in macrophages 
during mutant infection at 6 and 9 hours post infection, while myeloid differentiation primary 
response 116 (MYD116) and thymidylate kinase family (TYK1) genes are not significantly up 
regulated.  This evidence shows that the mutant is eliciting a host response specific to cytosol 
target genes within the overall immune gene up regulation.  Taking into account the similar 
patterns in up regulation of immune response genes in both mutant and wild-type infection, one 
should consider that the microarray was performed in BALB/c bone-marrow derived 
macrophages only and, as discussed, LLO and PC-PLC can have drastically different essential 
functions within different cell types.  Performing additional experiments in different cell lines 
could result in altered transcriptional profiles and in vivo examination of gene regulation would 
be much more informative, considering the complexity of the immune response. 
In this study we examined the attenuation of L. monocytogenes secreting constitutively 
active PC-PLC by the plcB∆pro mutant.  Efficiency of vacuolar escape and decreased 
mitochondrial fragmentation were demonstrated during mutant infection in vitro.  Further, 
murine inoculation results in attenuation of mutant bacteria and co-infected wild-type bacteria 
without increased cellular immune response and with decreased inflammatory cytokines, IFN-γ 
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and IL-12.  In vitro analysis of transcriptional response reveals few immune-related gene 
regulation changes in BMMΦ infection between mutant and wild-type strains. These combined 
results suggest that early host response to infection with the plcB∆pro mutant is responsible for 
reduced bacterial survivability within the mouse liver, independent of inflammatory response. 
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